title: Can pharmacists influence the health-related quality of life of patients with asthma?: The New Zealand Pharmaceutical Care experience.
abstract: BACKGROUND
  The newly emerging practice of Pharmaceutical Care requires that pharmacists take responsibility for the outcomes of drug therapy. Improvement in Quality of Life (QoL) represents the final outcome of the care process and indicates the success of interventions.
  
  
  OBJECTIVE
  To assess the impact of a Pharmaceutical Care specialist asthma service provided by community pharmacists to a sample of patients with asthma, the outcome indicators being changes in health status and QoL.
  
  
  METHODS
  Sixty-two adult asthma patients (17 years and older) living in two rural regions of New Zealand, were segregated into two groups for phased introduction to the service. The patients acted as their own controls before they received the pharmacists' service. They had been diagnosed with asthma at least six months previously, and their asthma was symptomatic and not considered optimally controlled prior to the study.
  
  
  RESULTS
  There was significant improvement in asthma-related QoL (as measured by the Asthma Quality of Life Questionnaire) following introduction of the service, and pharmacists were able to identify, prevent or resolve over 400 drug-related problems.
  
  
  CONCLUSIONS
  The results suggest that with appropriate training and support, New Zealand pharmacists can help asthma patients achieve greater quality of life. This research has implications for the introduction of Pharmaceutical Care services in other countries and for patients with other conditions who require ongoing management.
authors.affiliation: Division of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag 92019, Auckland, New Zealand.
authors.forename: N
authors.initials: N
authors.lastname: Kheir
authors.forename: L
authors.initials: L
authors.lastname: Emmerton
authors.forename: J
authors.initials: J
authors.lastname: Shaw
keywords: Pharmaceutical Care; Quality of Life; asthma; pharmacists
references.citation: Thorax. 1992 Feb;47(2):76-83
references.pmid: 1549827
references.citation: Chest. 1999 Mar;115(3):666-73
references.pmid: 10084473
references.citation: Pharmacotherapy. 1998 Nov-Dec;18(6):1365-74
references.pmid: 9855341
references.citation: Drug Intell Clin Pharm. 1988 Jan;22(1):63-7
references.pmid: 3349924
references.citation: Thorax. 1995 Jul;50(7):724-30
references.pmid: 7570405
references.citation: Clin Ther. 1997 Jan-Feb;19(1):113-23
references.pmid: 9083713
references.citation: Med Care. 1989 Mar;27(3 Suppl):S178-89
references.pmid: 2646488
references.citation: Am Rev Respir Dis. 1993 Sep;148(3):675-81
references.pmid: 8368640
references.citation: J Intern Med. 1991 Aug;230(2):157-64
references.pmid: 1865168
references.citation: Med Care. 1992 Jun;30(6):473-83
references.pmid: 1593914
references.citation: Am J Hosp Pharm. 1990 Mar;47(3):533-43
references.pmid: 2316538
references.citation: Eur Respir J. 1996 Apr;9(4):636-42
references.pmid: 8726924
references.citation: Respir Med. 1997 May;91(5):297-309
references.pmid: 9176649
references.citation: J Asthma. 2000 May;37(3):225-34
references.pmid: 10831147
references.citation: J Clin Epidemiol. 1992 Dec;45(12):1341-5
references.pmid: 1460470
references.citation: Thorax. 1995 Aug;50(8):851-7
references.pmid: 7570436
references.citation: J Am Pharm Assoc (Wash). 2000 Mar-Apr;40(2):174-80
references.pmid: 10730021
references.citation: Respir Med. 1999 Nov;93(11):763-9
references.pmid: 10603624
references.citation: Chest. 1999 May;115(5):1265-70
references.pmid: 10334138
references.citation: Eur Respir J. 1999 Jul;14(1):39-45
references.pmid: 10489827
references.citation: DICP. 1990 Nov;24(11):1093-7
references.pmid: 2275235
references.citation: BMJ. 1990 Dec 15;301(6765):1355-9
references.pmid: 2148702